Table 4.
Clinicopathological patient factors predictive of those likely to have further positive lymph nodes following completion axillary lymph node dissection.
| Parameter | Univariable |
Multivariable |
||||
|---|---|---|---|---|---|---|
| OR | 95% CI | P-value | OR | 95% CI | P-value | |
| Age < 75 | 1.104 | 0.198-6.156 | .910 | |||
| IDC subtype | 1.035 | 0.118-9.097 | .975 | |||
| Tumour size > 20 mm | 3.055 | 0.336-27.771 | .321 | |||
| Grade 3 | 0.460 | 0.082-2.588 | .378 | |||
| LVI | 0.998 | 0.957-1.040 | .910 | |||
| PgR− | 5.861 | 1.138-30.181 | .034a | 5.742 | 1.066-30.933 | .042* |
| ⩾ 3 +veLN on SLNB | 16.200 | 1.426-184.057 | .025a | 15.617 | 1.169-208.680 | .038* |
Abbreviations: CI, confidence interval; IDC, invasive ductal carcinoma; LVI, lymphovascular invasion; OR, odds ratio; PgR−, progesterone receptor negativity; SLNB, sentinel lymph node biopsy; +veLN, positive lymph nodes.
SLNB; sentinel lymph node biopsy.
*
denotes statistical significance.